Abdolahpour, Saeideh <br/><br/>
Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody.  [electronic resource] 

 -  Artificial cells, nanomedicine, and biotechnology  Feb 2018 
 - 89-94 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2169-141X 
<br/><br/><label>Standard No.: </label>10.1080/21691401.2017.1296847  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--chemistry<br/>Biological Transport<br/>Cell Survival--drug effects<br/>Doxorubicin--chemistry<br/>Drug Carriers--chemistry<br/>Drug Liberation<br/>ErbB Receptors--immunology<br/>Lipids--chemistry<br/>Mice<br/>NIH 3T3 Cells<br/>Nanostructures--chemistry<br/>Polyethylene Glycols--chemistry